Tamara Miller

21 papers receiving 935 citations

Hit Papers

Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial 2012 · 884 citations
8840+4+9Years since publication250500750

Peers

Tamara Miller
Comparison fields: 5 of 64
  • Pathology and Forensic Medicine 799
  • Neurology 319
  • Rheumatology 247
  • Immunology 244
  • Oncology 288
Replace M. Stojanovic with:
M. Stojanovic Serbia
Bella Ertik United States
Pedro Oyuela United States
Karthinathan Thangavelu United States
Ernesto Roldán Spain
T. Pickersgill United Kingdom
Pierangelo Barbero Italy
Lisa Costelloe Ireland
N. А. Totolyan Russia
Timon Bogumil Germany
Tamara Miller relative to M. Stojanovic Serbia M. Stojanovic's profile →
Citations per field
00.5×1.5×
M. Stojanovic · 1×
Citations per year

Countries citing papers authored by Tamara Miller

Since Specialization
Citations

This map shows the geographic impact of Tamara Miller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tamara Miller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tamara Miller more than expected).

Fields of papers citing papers by Tamara Miller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tamara Miller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tamara Miller. The network helps show where Tamara Miller may publish in the future.

Co-authors

The 25 scholars most cited alongside Tamara Miller, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Tamara Miller Line = papers co-authored together Tamara Miller links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial
Hit paper breakdown →
2012884
2 201214
3 20208
4 20196
5 20206
6 20226
7 20125
8 20125
9 20134
10 20133
11 20213
12 20192
13 20132
14 20042
15 20132
16 20131
17 20191
18 20131
19 20131
20 20131

About Tamara Miller

Tamara Miller is a scholar working on Pathology and Forensic Medicine, Neurology, Oncology, Immunology and Molecular Biology, having authored 23 papers that have together received 958 indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (16 papers), Polyomavirus and related diseases (5 papers), Peripheral Neuropathies and Disorders (5 papers), Acute Lymphoblastic Leukemia research (3 papers), Rheumatoid Arthritis Research and Therapies (3 papers), Immunodeficiency and Autoimmune Disorders (2 papers), Mycobacterium research and diagnosis (2 papers) and Immunotherapy and Immune Responses (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (799 citations), Neurology (319 citations), Rheumatology (247 citations), Immunology (244 citations) and Oncology (288 citations). Tamara Miller has collaborated with scholars based in United States, Canada and Czechia. Frequent co-authors include Eva Havrdová, Christian Confavreux, Edward Fox, Jeffrey Cohen, Michael Panzara, David Margolin, Krzysztof Selmaj, Douglas L. Arnold, Alasdair Coles and Howard L. Weiner. Their work appears in journals such as Neurology, Multiple Sclerosis and Related Disorders, The Journal of Clinical Endocrinology & Metabolism, International Journal of MS Care and The Lancet.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact